Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim Gal

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Experimental Pharmacology|September 23, 2024
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat StressMarella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, et al.
European Heart Journal. Cardiovascular Imaging|January 16, 2015
Association between pulmonary vein orientation and atrial fibrillation-free survival in patients undergoing endoscopic laser balloon ablationPim Gal, Joris F W Ooms, Jan Paul Ottervanger, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology|July 30, 2021
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trialBoukje C Eveleens Maarse, Claus Graff, Jørgen K Kanters, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary SyndromesMichael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Clinical and Translational Science|May 13, 2023
Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial diseaseSebastiaan J W van Kraaij, Diana R Pereira, Bastiaan Smal, et al.
Drug Testing and Analysis|June 25, 2019
Sensitivity and specificity of detection methods for erythropoietin doping in cyclistsJules A A C Heuberger, Peter van Eenoo, Joris I Rotmans, et al.
Scientific Reports|November 2, 2023
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severityAhnjili Zhuparris, Ghobad Maleki, Liesbeth van Londen, et al.
European Journal of Applied Physiology|June 16, 2020
Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletesJules A A C Heuberger, Jelle J Posthuma, Dimitrios Ziagkos, et al.
Journal of the American Heart Association|December 5, 2018
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up DataMihail G Chelu, Jordan B King, Eugene G Kholmovski, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Experimental Pharmacology|September 23, 2024
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat StressMarella C E van Ruissen, Sebastiaan J W van Kraaij, Pim Gal, et al.
European Heart Journal. Cardiovascular Imaging|January 16, 2015
Association between pulmonary vein orientation and atrial fibrillation-free survival in patients undergoing endoscopic laser balloon ablationPim Gal, Joris F W Ooms, Jan Paul Ottervanger, et al.
Clinical and Translational Science|July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial FibrillationPim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology|July 30, 2021
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trialBoukje C Eveleens Maarse, Claus Graff, Jørgen K Kanters, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 12, 2023
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary SyndromesMichael Böttcher, Hans-Dirk Düngen, Vasile Corcea, et al.
Clinical and Translational Science|May 13, 2023
Identification of peripheral vascular function measures and circulating biomarkers of mitochondrial function in patients with mitochondrial diseaseSebastiaan J W van Kraaij, Diana R Pereira, Bastiaan Smal, et al.
Drug Testing and Analysis|June 25, 2019
Sensitivity and specificity of detection methods for erythropoietin doping in cyclistsJules A A C Heuberger, Peter van Eenoo, Joris I Rotmans, et al.
Scientific Reports|November 2, 2023
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severityAhnjili Zhuparris, Ghobad Maleki, Liesbeth van Londen, et al.
European Journal of Applied Physiology|June 16, 2020
Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletesJules A A C Heuberger, Jelle J Posthuma, Dimitrios Ziagkos, et al.
Journal of the American Heart Association|December 5, 2018
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up DataMihail G Chelu, Jordan B King, Eugene G Kholmovski, et al.
Pageof 5